John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Compass
COMP
$9.06B
| $2M | ﹤0.01% |
229,261
-98,370
| -30% | -$779K |
|
1677
Vertex Pharmaceuticals
VRTX
$140B
| $2M | ﹤0.01% |
4,121
-29,039
| -88% | -$13.5M |
|
1678
Empire State Realty Trust
ESRT
$826M
| $2M | ﹤0.01% |
255,370
+69,774
| +38% | +$628K |
|
1679
SandRidge Energy
SD
$515M
| $1.99M | ﹤0.01% |
174,270
+35,830
| +26% | +$425K |
|
|
RWT
1680
Redwood Trust
RWT
$593M
| $1.99M | ﹤0.01% |
327,301
-29,115
| -8% | -$187K |
|
|
AXIA
1681
DELISTED
AXIA Energia
AXIA
| $1.99M | ﹤0.01% |
353,342
-46,195
| -12% | -$235K |
|
1682
Certara
CERT
$1.24B
| $1.98M | ﹤0.01% |
200,447
-177,077
| -47% | -$2.15M |
|
1683
Eldorado Gold
EGO
$12.6B
| $1.97M | ﹤0.01% |
117,244
-12,050
| -9% | -$181K |
|
1684
Rentokil
RTO
$12B
| $1.97M | ﹤0.01% |
85,833
-146,187
| -63% | -$3.53M |
|
1685
American Eagle Outfitters
AEO
$2.8B
| $1.96M | ﹤0.01% |
+169,036
| New | +$2.42M |
|
1686
Santander
BSBR
$43.4B
| $1.96M | ﹤0.01% |
416,563
+86,537
| +26% | +$387K |
|
1687
iShares US Tech Breakthrough Multisector ETF
TECB
$494M
| $1.96M | ﹤0.01% |
+40,100
| New | +$2.14M |
|
1688
Old Second Bancorp
OSBC
$1.28B
| $1.95M | ﹤0.01% |
117,462
-30,881
| -21% | -$553K |
|
1689
Element Solutions
ESI
$8.65B
| $1.95M | ﹤0.01% |
86,442
-36,039
| -29% | -$921K |
|
1690
Wave Life Sciences
WVE
$1.03B
| $1.95M | ﹤0.01% |
241,714
-149,906
| -38% | -$1.64M |
|
1691
Kanzhun
BZ
$7.28B
| $1.95M | ﹤0.01% |
101,764
-24,800
| -20% | -$404K |
|
1692
ONE Gas
OGS
$5.05B
| $1.95M | ﹤0.01% |
25,788
+7,935
| +44% | +$572K |
|
1693
Blue Owl Capital
OWL
$18.4B
| $1.94M | ﹤0.01% |
96,900
-223,349
| -70% | -$5.02M |
|
1694
Goosehead Insurance
GSHD
$2.57B
| $1.94M | ﹤0.01% |
16,416
+616
| +4% | +$69.1K |
|
|
NVRO
1695
DELISTED
NEVRO CORP.
NVRO
| $1.93M | ﹤0.01% |
330,902
+111,583
| +51% | +$588K |
|
1696
Univest Financial
UVSP
$1.14B
| $1.93M | ﹤0.01% |
68,112
+37,040
| +119% | +$1.1M |
|
1697
MasTec
MTZ
$19.8B
| $1.93M | ﹤0.01% |
16,548
-10,526
| -39% | -$1.42M |
|
1698
Emergent Biosolutions
EBS
$289M
| $1.93M | ﹤0.01% |
396,800
-449,966
| -53% | -$3.72M |
|
|
FSUN
1699
FirstSun Capital Bancorp
FSUN
$1.77B
| $1.92M | ﹤0.01% |
53,203
+15,103
| +40% | +$602K |
|
1700
Tidewater
TDW
$4.59B
| $1.92M | ﹤0.01% |
+45,368
| New | +$2.26M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.